Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis

Ofloxacin is widely used for the treatment of multidrug-resistant tuberculosis (MDR-TB). Data on its pharmacokinetics and safety in children are limited. It is not known whether the current internationally recommended pediatric dosage of 15 to 20 mg/kg of body weight achieves exposures reached in ad...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Antimicrob Agents Chemother
Egile Nagusiak: Garcia-Prats, Anthony J., Draper, Heather R., Thee, Stephanie, Dooley, Kelly E., McIlleron, Helen M., Seddon, James A., Wiesner, Lubbe, Castel, Sandra, Schaaf, H. Simon, Hesseling, Anneke C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2015
Gaiak:
Clinical Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4576031/
https://ncbi.nlm.nih.gov/pubmed/26195507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01404-15
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak